Genmab

Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Motley Fool
Sat, 08/5/17 - 09:43 am
JNJ
devices
baby boomers
specialty medicines
M&A
Genmab
Imbruvica
Looking for Darzalex sales expansion, J&J, Genmab hit a wall in lymphoma
Fierce Pharma
Tue, 04/4/17 - 07:29 pm
Darzalex
JNJ
Genmab
non-Hodgkin's lymphoma
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Motley Fool
Sat, 02/25/17 - 03:21 pm
JNJ
Remicade
Darzalex
Genmab
Multiple Myeloma
Gilead licenses bi-specific tech from Danish biotech Genmab
BioPharma Dive
Sat, 08/13/16 - 02:38 pm
Gilead Sciences
Genmab
HIV
Novartis stops PhIII trial of Genmab's Arzerra after buying rights from GSK
Fierce Biotech
Fri, 03/11/16 - 10:36 am
Novartis
Genmab
Arzerra
GSK
pemphigus vulgaris
J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex
Fierce Biotech
Mon, 11/16/15 - 03:29 pm
JNJ
Multiple Myeloma
daratumumab
FDA
Darzalex
Genmab
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Novo Nordisk ties the R&D knot with Genmab, and they're not focused on cancer
Fierce Biotech
Fri, 08/14/15 - 11:20 am
Genmab
Novo Nordisk
R&D
Novartis files leukemia drug Arzerra in the EU
BioPharma Dive
Thu, 07/9/15 - 07:42 pm
Novartis
Arzerra
Europe
Genmab
CLL
chronic lymphocytic leukemia
Genmab shares rise on cancer drug's FDA license application
Yahoo/Reuters
Mon, 06/8/15 - 10:07 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Amgen hands off an IL-15 drug--strings attached--for upstart effort on celiac disease
Fierce Biotech
Mon, 03/2/15 - 08:14 am
Amgen
celiac disease
AMG 714
Genmab
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
Thu, 12/4/14 - 04:13 pm
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
J&J hands over $25M milestone for daratumumab progress
Fierce Biotech
Mon, 07/7/14 - 11:25 am
JNJ
daratumumab
Genmab
Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
The Fly on the Wall
Mon, 05/19/14 - 03:17 pm
GSK
Genmab
ofatumumab
large B-cell lymphoma
Genmab earnings boosted by Janssen collaboration
Yahoo/Reuters
Wed, 05/7/14 - 03:30 pm
Genmab
earnings
Janssen
Denmark's Genmab expands biotech collaboration with Janssen
Reuters
Wed, 12/4/13 - 11:44 am
Genmab
Janssen
Duobody antibodies
Milestone payment triggers Genmab guidance increase
Yahoo/Reuters
Tue, 11/26/13 - 09:00 am
Genmab
daratumumab
JNJ
Janssen
GSK/Genmab file Arzerra for first-line CLL
Pharma Times, UK
Mon, 10/21/13 - 09:56 am
Arzerra
GSK
Genmab
CLL
chronic lymphocytic leukemia
Genmab announces positive results for sclerosis drug candidate
Reuters
Thu, 10/10/13 - 06:19 pm
Genmab
MS
multiple sclerosis
ofatumumab
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Yahoo/Globe Newswire
Sat, 10/5/13 - 09:31 am
ofatumumab
GSK
Genmab
Arzerra
leukemia
chronic lymphocytic leukemia

Pages